Riskpilot← Back to searchSign inGet full accessSkansen kliniken AB
ABActiveOrg 5590775382Kastellgatan 14Dental practice care activities · NACE 8623Est. 20161-4 employees
Revenue 2024
SEK 4,3M
-12% vs 2023
EBITDA margin
3.4%
+47% vs 2023
Equity ratio
11.5%
Financial strength
Net profit 2024
SEK 74K
+90% vs 2023
| Revenue | SEK 4,3M | -12% |
| EBITDA | SEK 146K | +47% |
| Net profit | SEK 74K | +90% |
| Total assets | SEK 1,8M | -18% |
| Equity | SEK 204K | +58% |
| Employees | — | — |
Legal name
Skansen kliniken AB
Org number
5590775382
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
26 september 2016
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva tandläkarverksamhet.
Address
Kastellgatan 14
Email
ahmed_hassan86@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 385 | 3 579 | 4 565 | 4 823 | 4 255 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 558 | −615 | 630 | 99 | 146 |
| Depreciation & amort. | −54 | −62 | −62 | −54 | −43 |
| EBIT | 504 | −677 | 568 | 45 | 103 |
| Net financials | −17 | −34 | −29 | −6 | −28 |
| Profit before tax | 286 | −511 | 538 | 39 | 74 |
| Tax | −213 | −75 | −143 | −0 | −0 |
| Net profit | 73 | −586 | 395 | 39 | 74 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 960 | 1 502 | 2 003 | 2 173 | 1 778 |
| Equity | 131 | −455 | 90 | 129 | 204 |
| Long-term debt | 830 | 933 | 751 | 711 | 590 |
| Short-term debt | 799 | 1 024 | 1 162 | 1 333 | 985 |
| Total debt | 1 629 | 1 957 | 1 913 | 2 044 | 1 575 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
11.5%
This company
38.2%
Market median
-70% vs market
20202024
Return on equity
36.3%
This company
18.4%
Market median
+97% vs market
20202024
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
20202024
Asset turnover
2.39×
This company
1.12×
Market median
+113% vs market
20202024
Debt / equity
7.72×
This company
0.62×
Market median
-1145% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AF Chief Executive Officer | Chief Executive Officer | 2024 |
| Audit | 2025 | |
| Former (2) | ||
| Audit | 2022 – 2025 | |
NL | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2024 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Skansen kliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Louise Rebecka Thérese Jonasson | Audit | 0 companies |
| Nils Lars Johan Magnusson | Audit | 0 companies |
| Ahmed Fadhil Hassan | Chief Executive Officer | 0 companies |
| Alf Niclas Ljunggren-Weidmann | Audit | 0 companies |
| Noor Fadhil Abbas Hassan | Board of Directors | 0 companies |
| Ahmed Balasim Joudah Oleiwi Hassan | Deputy Board Member | 0 companies |
| Elaf Balasim Joudah Oleiwi | Board of Directors | 0 companies |